214
Participants
Start Date
January 21, 2021
Primary Completion Date
May 14, 2025
Study Completion Date
May 14, 2025
OFEV®
nintedanib
National Taiwan University Hospital, Taipei
Taipei Medical University Hospital, Taipei
Shin Kong Wu Ho-Su Memorial Hospital, Taipei
Tri-Service General Hospital, Taipei
Taipei Tzu Chi General Hospital, New Taipei City
Taipei Medical University-Shuang Ho Hospital, New Taipei City
National Taiwan University Hospital-Hsin-Chu Branch, Hsinchu
Chang Gung Memorial Hospital(Linkou), Taoyuan District
Cheng Ching Hospital, Taichung
Asia University Hospital, Taichung
Chang-Hua Christian Hospital, Changhua
Chang Gung Memorial Hospital Chiayi, Chiayi City
National Taiwan University Hospital Yun-Lin Branch, Yunlin County
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
E-Da Hospital, Kaohsiung City
Taitung MacKay Memorial Hospital, Taitung
Mackay Memorial Hospital, Taipei
Taipei Veterans General Hospital, Taipei
National Yang-Ming University Hospital, Yilan
Chung Shan Medical University Hospital, Taichung
Taichung Veterans General Hospital, Taichung
Kaohsiung Veterans General Hospital, Kaohsiung City
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City
China Medical University Hospital, Taichung
Cheng Hsin Rehabilitation Medical Center, Taipei
TaoYuan General Hospital, Taoyuan
Lead Sponsor
Boehringer Ingelheim
INDUSTRY